COVID‐19 and immunosuppressive therapy in dermatology

Coronavirus 2019 (COVID 19) was first detected in December 2019 in China. It has become a pandemic. With concern about therapies that may decrease immunity and enhance the severity of an individual's COVID‐19 infection, leading to a possibly fatal outcome, use of immunosuppressants has become a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Dermatol Ther
Autors principals: Schwartz, Robert A., Pradhan, Swetalina, Murrell, Dedee F., Jafferany, Mohammad, Olisova, Olga Y., Lomonosov, Konstantin M., Lotti, Torello, Goldust, Mohamad
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2020
Matèries:
Review Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7435553/
https://ncbi.nlm.nih.gov/pubmed/32770592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dth.14140
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars